MetLife Investment Management, LLC - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2020$113,800
+16.0%
6,205
+0.1%
0.00%0.0%
Q1 2020$98,068
-11.1%
6,199
-0.7%
0.00%0.0%
Q4 2018$110,269–6,244–0.00%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders